Clinical Trial Update: The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 MADe IT trial used molecular analyses to direct individualized therapy for advanced non-small cell lung cancer; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED | Results posted: 2011-02-23